NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.

Authors :: Schaeffer EM
Srinivas S
Adra N
An Y
Bitting R
Chapin B
Cheng HH
D'Amico AV
Desai N
Dorff T
Eastham JA
Farrington TA
Gao X
Gupta S
Guzzo T
Ippolito JE
Karnes RJ
Kuettel MR
Lang JM
Lotan T
McKay RR
Morgan T
Pow-Sang JM
Reiter R
Roach M
Robin T
Rosenfeld S
Shabsigh A
Spratt D
Szmulewitz R
Teply BA
Tward J
Valicenti R
Wong JK
Snedeker J
Freedman-Cass DA
Source :: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Apr; Vol. 22 (3), pp. 140-150.
Publication Year :: 2024
Abstract: The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.